Related Experiment Videos
Cystic fibrosis, pathophysiological and clinical aspects
H J Neijens1, M Sinaasappel, R de Groot
1Department of Paediatrics, Ersasmus University, Rotterdam, The Netherlands.
European Journal of Pediatrics
|August 1, 1990
Summary
Cystic fibrosis (CF) is a genetic disease causing progressive organ damage. Current treatments manage symptoms like infections and improve nutrition, extending median survival to 25 years.
Area of Science:
- Medical Genetics
- Pulmonology
- Hereditary Diseases
Background:
- Cystic fibrosis (CF) is a lethal, hereditary disease with progressive multi-organ dysfunction.
- Genetic and cellular mechanisms of CF are increasingly understood.
- Current CF therapies are largely symptomatic and lack robust evidence.
Purpose of the Study:
- To summarize current knowledge on cystic fibrosis disease mechanisms.
- To review contemporary therapeutic strategies for cystic fibrosis.
- To highlight advancements in CF patient care and outcomes.
Main Methods:
- Literature review of recent studies on CF.
- Synthesis of information on genetic and cellular basis of CF.
- Analysis of current treatment approaches, including infection control, airway clearance, and supportive care.
Main Results:
- Median survival for cystic fibrosis patients has increased significantly.
- Therapeutic strategies focus on managing respiratory infections and optimizing nutritional and physical status.
- Despite progress, CF treatment remains primarily symptomatic.
Conclusions:
- Significant advancements have been made in understanding cystic fibrosis.
- Improved management strategies have led to increased median survival.
- Further research is needed for more effective, evidence-based CF therapies.